Jayamas Medica (Indonesia) Performance
| OMED Stock | 165.00 2.00 1.20% |
The company retains a Market Volatility (i.e., Beta) of -0.21, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Jayamas Medica are expected to decrease at a much lower rate. During the bear market, Jayamas Medica is likely to outperform the market. At this point, Jayamas Medica Industri has a negative expected return of -0.21%. Please make sure to check out Jayamas Medica's skewness, accumulation distribution, rate of daily change, as well as the relationship between the kurtosis and daily balance of power , to decide if Jayamas Medica Industri performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Jayamas Medica Industri has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's forward-looking signals remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
| Other Cashflows From Financing Activities | -10 B | |
| Total Cashflows From Investing Activities | -187.1 B |
Jayamas |
Jayamas Medica Relative Risk vs. Return Landscape
If you would invest 18,700 in Jayamas Medica Industri on December 17, 2024 and sell it today you would lose (2,200) from holding Jayamas Medica Industri or give up 11.76% of portfolio value over 90 days. Jayamas Medica Industri is generating negative expected returns and assumes 1.1474% volatility on return distribution over the 90 days horizon. Simply put, 10% of stocks are less volatile than Jayamas, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Jayamas Medica Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jayamas Medica's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Jayamas Medica Industri, and traders can use it to determine the average amount a Jayamas Medica's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1822
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | OMED |
Estimated Market Risk
| 1.15 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Jayamas Medica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jayamas Medica by adding Jayamas Medica to a well-diversified portfolio.
Jayamas Medica Fundamentals Growth
Jayamas Stock prices reflect investors' perceptions of the future prospects and financial health of Jayamas Medica, and Jayamas Medica fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Jayamas Stock performance.
| Return On Equity | 0.52 | |||
| Return On Asset | 0.29 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.31 % | |||
| Current Valuation | 5.63 T | |||
| Shares Outstanding | 27.06 B | |||
| Price To Book | 5.55 X | |||
| Price To Sales | 2.76 X | |||
| Revenue | 2.19 T | |||
| EBITDA | 697.78 B | |||
| Book Value Per Share | 46.00 X | |||
| Cash Flow From Operations | 505.11 B | |||
| Earnings Per Share | 16.47 X | |||
About Jayamas Medica Performance
By examining Jayamas Medica's fundamental ratios, stakeholders can obtain critical insights into Jayamas Medica's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Jayamas Medica is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Jayamas Medica Industri performance evaluation
Checking the ongoing alerts about Jayamas Medica for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Jayamas Medica Industri help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Jayamas Medica generated a negative expected return over the last 90 days |
- Analyzing Jayamas Medica's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Jayamas Medica's stock is overvalued or undervalued compared to its peers.
- Examining Jayamas Medica's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Jayamas Medica's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Jayamas Medica's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Jayamas Medica's stock. These opinions can provide insight into Jayamas Medica's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Jayamas Stock
Jayamas Medica financial ratios help investors to determine whether Jayamas Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jayamas with respect to the benefits of owning Jayamas Medica security.